Enliven Therapeutics Competitors and Similar CompaniesClear all
Enliven Therapeutics's competitors and similar companies include CARsgen Therapeutics, Day One Biopharmaceuticals, Artiva Biotherapeutics and Iksuda Therapeutics.
 Enliven Therapeutics Enliven Therapeutics is a biopharmaceutical company that specializes in cancer treatment solutions. |  CARsgen Therapeutics CARsgen Therapeutics is a clinical-stage immune-oncology company that develops a new chimeric T-cell antigen receptor for liver, lung, stomach and brain cancers treatment. |  Day One Biopharmaceuticals Day One Biopharmaceuticals is a company that develops drugs and therapies intended to find a cure for cancer. |  Artiva Biotherapeutics Artiva Biotherapeutics is a company that develops off-the-shelf cell therapies designed to treat hematologic malignancies or solid tumors. |  Iksuda Therapeutics Iksuda is a biotechnology company that focuses on developing antibody-based therapies for the treatment of cancer. | |
Founding Date | Founding Date 2019 | Founding Date 2014 | Founding Date 2018 | Founding Date 2019 | Founding Date 2007 |
Type | Type Public | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations HQ | Locations Shanghai, CN HQ Beijing, CN Shanghai, CN Shanghai, CN Bellaire, US | Locations South San Francisco, US HQ | Locations San Diego, US HQ | Locations Newcastle upon Tyne, GB HQ Newton, US |
Employees | Employees N/A | Employees 100 | Employees 20 | Employees 81 | Employees 43 |
Valuation ($) | Valuation ($) 1.3 b | Valuation ($) N/A | Valuation ($) 1.4 b | Valuation ($) 263.8 m | Valuation ($) N/A |
Financial | |||||
Net income | Net income N/A | Net income N/A | Net income ($107.3m) (FY, 2025) | Net income ($83.9m) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 186m (over 5 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 47m (almost 5 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 276m | Total funding raised $ 60m | Total funding raised $ 78m | Total funding raised $ 47m |
For sources of this data, please see the company profile
View Company Profiles
CARsgen Therapeutics
HQ
Shanghai, CN
Employees
100
CARsgen Therapeutics is a clinical-stage immune-oncology company that develops a new chimeric T-cell antigen receptor for liver, lung, stomach and brain cancers treatment.
View companyDay One Biopharmaceuticals
HQ
South San Francisco, US
Employees
20
Day One Biopharmaceuticals is a company that develops drugs and therapies intended to find a cure for cancer.
View companyArtiva Biotherapeutics
HQ
San Diego, US
Employees
81
Artiva Biotherapeutics is a company that develops off-the-shelf cell therapies designed to treat hematologic malignancies or solid tumors.
View companyIksuda Therapeutics
HQ
Newcastle upon Tyne, GB
Employees
43
Iksuda is a biotechnology company that focuses on developing antibody-based therapies for the treatment of cancer.
View company